The cationic amphiphilic drug hexamethylene amiloride eradicates bulk breast cancer cells and therapy-resistant subpopulations with similar efficiencies
Berg et al.; Cancers (Basel). 2022 Feb 14;14(4):949
Choose your Region
Please choose your region for an optimized website experience. So we can provide you with the most useful information for your country.